17 results
PRE 14A
OMIC
Singular Genomics Systems Inc
5 Apr 24
Preliminary proxy
4:30pm
This Proxy Material and Voting
Directors, Executive Officers and Corporate Governance
Security Ownership of Certain Beneficial Owners and Management
Section 16 … AND CORPORATE GOVERNANCE
Executive Officers, Key Employees and Directors
Our executive officers, key employees and directors, and certain information
8-K
OMIC
Singular Genomics Systems Inc
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:29pm
and comply with Nasdaq’s corporate governance requirements.
As previously disclosed, on July 17, 2023, the Company received a letter from Nasdaq
S-3
EX-1.2
jrt1nll m66m884g
19 Jul 22
Shelf registration
4:16pm
DEF 14A
dx0bh64exmy ptyr5
14 Apr 22
Definitive proxy
5:00pm
10-K
ekfd2 oz7u8w
14 Mar 22
Annual report
4:06pm
8-K
EX-3.2
mnfor7g
1 Jun 21
Singular Genomics Systems, Inc. Announces Closing of
4:46pm
424B4
osxhobft2njm8pslc8
28 May 21
Prospectus supplement with pricing info
12:00am
S-1/A
f1c cciu0zc48va020o
12 May 21
IPO registration (amended)
5:12pm
S-1
hxai tb410fj
7 May 21
IPO registration
4:18pm
DRS/A
o2y8onbk
26 Apr 21
Draft registration statement (amended)
12:00am
DRS
l6oy26
22 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next